Human Vγ9Vδ2 T cells: promising new leads for immunotherapy of infections and tumors
- 1 October 2006
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 18 (5), 539-546
- https://doi.org/10.1016/j.coi.2006.07.002
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Analysis of mechanism for human γδ T cell recognition of nonpeptide antigensBiochemical and Biophysical Research Communications, 2005
- Human Keratinocytes Release ATP and Utilize Three Mechanisms for Nucleotide Interconversion at the Cell SurfaceJournal of Biological Chemistry, 2005
- Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac DiseaseImmunity, 2004
- The interplay between classical and alternative isoprenoid biosynthesis controls γδ T cell bioactivity of Listeria monocytogenesFEBS Letters, 2004
- Expression and synthesis of fibroblast growth factor-9 in human γδ T-lymphocytes. Response to isopentenyl pyrophosphate and TGF-β1/IL-15Journal of Leukocyte Biology, 2004
- Effect Of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID MiceCancer Research, 2004
- Differentiation of Resting Human Peripheral Blood γδ T Cells toward Th1- or Th2-PhenotypeCellular Immunology, 2001
- γδ Cells: A Right Time and a Right Place for a Conserved Third Way of ProtectionAnnual Review of Immunology, 2000
- RECOGNITION BY γ/δ T CELLSAnnual Review of Immunology, 1996
- Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial LigandsScience, 1994